We are live on ! Find out more
CI

Capital International Portfolio holdings

AUM $2.7B
1-Year Est. Return 31.08%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+31.08%
3 Year Est. Return
+123.92%
5 Year Est. Return
+171.61%
10 Year Est. Return
+862.17%
AUM
$1.42B
AUM Growth
+$35M
Cap. Flow
-$56.8M
Cap. Flow %
-4.02%
Top 10 Hldgs %
27.59%
Holding
142
New
4
Increased
25
Reduced
46
Closed
3

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$24.1M
2
NWL icon
Newell Brands
NWL
+$12.2M
3
PG icon
Procter & Gamble
PG
+$10.1M
4
DHR icon
Danaher
DHR
+$8.73M
5
INCY icon
Incyte
INCY
+$4.15M

Sector Composition

Rank Sector Weight
1 Technology 13.85%
2 Financials 13.25%
3 Healthcare 12.84%
4 Energy 12.51%
5 Consumer Discretionary 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PARA
26
DELISTED
Paramount Global Class B
PARA
$17.9M 1.27%
327,300
+96,400
+42% +$5.11M
XLNX
27
DELISTED
Xilinx Inc
XLNX
$17.3M 1.22%
318,600
-13,100
-4% -$673K
CMCSA icon
28
Comcast
CMCSA
$85.8B
$17M 1.2%
512,800
CIT
29
DELISTED
CIT Group Inc.
CIT
$17M 1.2%
467,700
+2,700
+0.6% +$94.3K
MRSH
30
Marsh
MRSH
$91.7B
$16.6M 1.17%
246,500
-17,500
-7% -$1.17M
BABA icon
31
Alibaba
BABA
$276B
$15.8M 1.12%
149,550
+90,400
+153% +$8.38M
ICE icon
32
Intercontinental Exchange
ICE
$86.4B
$15.1M 1.07%
280,225
DLR icon
33
Digital Realty Trust
DLR
$71.5B
$15.1M 1.07%
1,106,021
VALE.P
34
DELISTED
Vale S A
VALE.P
$14.1M 0.99%
2,989,800
-185,900
-6% -$844K
ILMN icon
35
Illumina
ILMN
$29.2B
$14M 0.99%
79,459
-9,355
-11% -$1.5M
AGIO icon
36
Agios Pharmaceuticals
AGIO
$2.14B
$13.9M 0.98%
262,800
+2,200
+0.8% +$95.8K
LLY icon
37
Eli Lilly
LLY
$1.09T
$13.6M 0.96%
169,500
-50,400
-23% -$4.03M
CVX icon
38
Chevron
CVX
$374B
$13.3M 0.94%
129,432
+5,900
+5% +$602K
UNP icon
39
Union Pacific
UNP
$175B
$13.2M 0.93%
135,000
ON icon
40
ON Semiconductor
ON
$32.8B
$13M 0.92%
1,052,000
CNI icon
41
Canadian National Railway
CNI
$78.3B
$12.9M 0.91%
196,800
WYNN icon
42
Wynn Resorts
WYNN
$10.3B
$12.5M 0.89%
128,700
-28,800
-18% -$2.81M
JNJ icon
43
Johnson & Johnson
JNJ
$643B
$12.5M 0.88%
105,500
HXL icon
44
Hexcel
HXL
$8.3B
$12M 0.85%
271,502
-10,700
-4% -$468K
GILD icon
45
Gilead Sciences
GILD
$167B
$11.2M 0.79%
141,007
-45,350
-24% -$3.68M
RARE icon
46
Ultragenyx Pharmaceutical
RARE
$2.56B
$11.1M 0.79%
+157,000
New +$10M
NWL icon
47
Newell Brands
NWL
$2.24B
$11M 0.78%
209,300
-235,085
-53% -$12.2M
CERN
48
DELISTED
Cerner Corp
CERN
$10.9M 0.77%
177,300
STJ
49
DELISTED
St Jude Medical
STJ
$10.9M 0.77%
136,390
-3,700
-3% -$299K
OXY icon
50
Occidental Petroleum
OXY
$53.6B
$10.8M 0.77%
148,550

Similar funds

Capital International's Q3 2016 Portfolio in Review

As of Q3 2016, Capital International held 142 positions worth $1.42B, up 2.5% from $1.38B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Capital International withdrew a net $56.8M in Q3 2016, closing 3 positions and reducing 46 holdings. Its most notable exit was The Mosaic Company, an estimated $105K position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Capital International opened a new position in Ultragenyx Pharmaceutical worth $11.1M.

  • Capital International's largest Q3 2016 buy was Ultragenyx Pharmaceutical: 157,000 shares worth $11.1M.
  • Capital International added most to Alibaba in Q3 2016, an estimated $8.38M increase.
  • Capital International's biggest Q3 2016 reduction was Goldman Sachs, cutting an estimated $24.1M.
  • Capital International fully exited The Mosaic Company in Q3 2016, selling an estimated $105K.
  • Capital International's ten largest holdings make up 28% of its $1.42B portfolio in Q3 2016.
  • Capital International opened 4 new positions and closed 3 in Q3 2016.
  • Capital International's portfolio value rose 2.5% quarter-over-quarter to $1.42B.

Based on Capital International's 13F filing for Q3 2016, filed 14 Nov 2016.